IART vs LIN · rev $810.7M vs P/E 34, rev $18.07B
Integra LifeSciences Holdings (IART) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported IART revenue for 2026-06-30 was $810.7M. Net income was -$134.0K. IART currently screens at market cap $1.32B.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
IART currently screens at market cap $1.32B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the IART and LIN stock pages for the full models.
Not investment advice.